Synthetic BiologybioRxivPreprint
Low-cost drug discovery with engineered E. coli reveals an anti-mycobacterial activity of benazepril
Nadine Bongaerts, Zainab Edoo, Ayan A. Abukar…·Edwin H. Wintermute
The paper uses engineered E. coli to screen for Mtb inhibitors, identifying benazepril as an anti-mycobacterial drug with a novel mechanism.
DOI 10.1101/2021.03.26.437171